Agusti Alentorn

13PUBLICATIONS
64CO-AUTHORS
Particle and high energy physics not elsewhere classifiedPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 20, 2026
QuRad: Radiomics Feature Extraction for QuPath.

|Sep 23, 2026
Plasma proteomics for prognostic stratification in newly diagnosed primary central nervous system lymphoma.

|Jul 27, 2026
Spatial analysis of paraneoplastic cerebellar degeneration in ovarian cancer with anti-Yo syndrome and SCA1.

|Mar 27, 2025
Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma Network.

Hugo Hernández-Tost, Nicolas Weiss, Sylvain Choquet

|Oct 02, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Salah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret

|Aug 08, 2024
Epilepsy in Patients With Primary CNS Lymphoma: Prevalence, Risk Factors, and Prognostic Significance.

Oumaima Aboubakr, Caroline Houillier, Agusti Alentorn

Pageof 3

Frequent Collaborators

4 joint publications

Caroline Houillier

3 joint publications

Bertrand Mathon

3 joint publications

Lucia Nichelli

3 joint publications

Stefania Cuzzubbo